[Comparison of the biological availability of retard and non-retard lisuride tablets in dogs].
作者信息
Lapka R, Pospísil A, Sedlmayer P, Rejholec V, Rezanka V, Smolík S, Franc Z
出版信息
Cesk Farm. 1985 Feb;34(1):3-6.
PMID:3986933
Abstract
摘要
相似文献
1
[Comparison of the biological availability of retard and non-retard lisuride tablets in dogs].[犬中缓释型和非缓释型利苏脲片生物利用度的比较]
Cesk Farm. 1985 Feb;34(1):3-6.
2
[Relative biological availability of quinidine VUFB retard tablets in dogs].[奎尼丁VUFB缓释片在犬体内的相对生物利用度]
Cesk Farm. 1983 Jul;32(5):164-6.
3
Disposition of oral lisuride in Parkinson's disease.帕金森病中口服利苏立肽的处置情况。
Clin Pharmacol Ther. 1984 Apr;35(4):548-56. doi: 10.1038/clpt.1984.76.
4
5
6
Enhancement of ketoprofen bioavailability by formation of microsponge tablets.通过制备微球片提高酮洛芬的生物利用度。
Pharmazie. 2007 Jan;62(1):51-4.
7
Pharmacokinetics and pharmacodynamics of the ergot derivative, transdihydrolisuride, in man.麦角衍生物曲二氢麦角隐亭在人体中的药代动力学和药效学
Eur J Clin Pharmacol. 1984;27(3):335-9. doi: 10.1007/BF00542171.
8
Lisuride in extrapyramidal disorders: a possible mechanism of action.利苏瑞德治疗锥体外系疾病：一种可能的作用机制
Adv Neurol. 1984;40:523-6.
9
[Absolute bioavailability of theophylline (Euphylline)].[茶碱（优喘平）的绝对生物利用度]
Fortschr Med. 1980 Nov 20;98(43):1707-10.
10
Pharmacokinetics of lisuride after subcutaneous infusion.皮下输注后利苏瑞肽的药代动力学
J Neural Transm Suppl. 1988;27:71-4. doi: 10.1007/978-3-7091-8954-2_8.
Zotero 插件